Literature DB >> 1695947

Site-specific phosphorylation of the middle molecular weight human neurofilament protein in transfected non-neuronal cells.

S J Pleasure1, V M Lee, D L Nelson.   

Abstract

We expressed the human midsized neurofilament subunit (NF-M) using genomic DNA in mouse L cells and showed that it is transcribed and translated into a protein capable of assembly into the cytoskeleton and of forming a filamentous network that colocalizes with the endogenous vimentin filaments. Moreover, human NF-M expressed in L cells is phosphorylated at sites within the multiphosphorylation repeat (MPR), i.e., the major sites of phosphorylation of NF-M in vivo. We also expressed a genomic construct lacking the MPR domain in the native molecule and showed that this MPR(-) protein also was expressed and formed a filamentous network despite diminished incorporation of radiolabeled phosphate. Two major conclusions emerged from the work described in this paper: human NF-M is translated, assembled, and phosphorylated at physiological sites without the need of any other specific neuronal proteins; phosphorylation sites other than the MPR are present within NF-M which may play a role in synthesis, assembly, and degradation of NF protein in humans.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695947      PMCID: PMC6570384     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  8 in total

1.  Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons.

Authors:  S E Merrick; J Q Trojanowski; V M Lee
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

2.  Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus.

Authors:  J M Parent; T W Yu; R T Leibowitz; D H Geschwind; R S Sloviter; D H Lowenstein
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

3.  Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology.

Authors:  M A McCall; R G Gregg; R R Behringer; M Brenner; C L Delaney; E J Galbreath; C L Zhang; R A Pearce; S Y Chiu; A Messing
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

4.  Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice.

Authors:  A Messing; M W Head; K Galles; E J Galbreath; J E Goldman; M Brenner
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

5.  The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells.

Authors:  J H Simon; R A Fouchier; T E Southerling; C B Guerra; C K Grant; M H Malim
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Vif and the p55(Gag) polyprotein of human immunodeficiency virus type 1 are present in colocalizing membrane-free cytoplasmic complexes.

Authors:  J H Simon; E A Carpenter; R A Fouchier; M H Malim
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

7.  Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Implications for the pathogenesis of myasthenia gravis.

Authors:  A Marx; A Wilisch; A Schultz; A Greiner; B Magi; V Pallini; B Schalke; K Toyka; W Nix; T Kirchner; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

8.  Co-expression of low molecular weight neurofilament protein and glial fibrillary acidic protein in established human glioma cell lines.

Authors:  T Tlhyama; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.